Home / News
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Patients on venetoclax for CLL, SLL, or AML often need antifungal prophylaxis — but azole antifungals complicate dosing. New guidance on how to optimize safety and efficacy.
Dr. Grant Drew, PharmD; et al. April 16, 2026
All FDA Approvals
All Cancer Types Endometrial Cancer Hematologic Malignancies Leukemia Lymphoma Multiple Myeloma Non-Small Cell Lung Cancer Prostate Cancer
All Diagnostics + Biomarkers Screening
All Therapeutic Approaches Chemotherapy Immunotherapy Targeted Therapy

What are you looking for?

Popular Searches

Oncology Practice Management Navigation